Clinical Trial Update: Efficacy and Safety of SCT200 in Patients With Advanced Squamous Non-small Cell Lung Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial update evaluating the preliminary efficacy and safety of SCT200 in patients with advanced squamous non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• SCT200

Snippet

Sponsor: Sinocelltech Ltd. | Conditions: Advanced Squamous Non-small Cell Lung Cancer | Phase 1 | Status: UNKNOWN